Dihydroartemisinin-piperaquine treatment of multidrug resistant falciparum and vivax malaria in pregnancy
January 17, 2014
Background Artemisinin combination therapy (ACT) is recommended for the treatment of multidrug resistant malaria in the second and third trimesters…
Major burden of severe anemia from non-falciparum malaria species in southern Papua: A hospital-based surveillance study
December 17, 2013
This paper highlights the central role of anaemia in the aetiology of severe vivax malaria.
Low antibody levels to pregnancy-specific malaria antigens and heightened cytokine responses associated with severe malaria in pregnancy
November 25, 2013
Sudanese pregnant women with severe malaria had low levels of pregnancy-specific antibody suggesting low immunity, and had high blood cytokine levels. Lack of immunity may predispose to severe pregnancy malaria.
August 1, 2013
This paper outlines spatial decision support tools that have been adopted by control programs.
Identification and prioritization of merozoite antigens as targets of protective human immunity to falciparum malaria for vaccine and biomarker development
June 17, 2013
The first comprehensive evaluation of merozoite antigens as targets of human immunity, including 96 antigens, which examined responses in detail in a longitudinal cohort of over 200 children. The study identified several antigens as strong targets of protective immunity that underpins a rational approach to vaccine development and biomarker development.
March 26, 2013
Antimalarial resistance is poorly understood, yet potentially devastating. We introduced a cutting edge experimental procedure and mathematical framework to probe the development of drug resistance.
Force of infection is key to understanding the epidemiology of Plasmodium falciparum malaria in Papua New Guinean children
June 4, 2012
This study established a new molecular-epidemiological metric of malaria transmission, the molecular force of infections, and demonstrated that it is the key determinant of the risk of P. falciparum infections and disease in young PNG children.
Intermittent preventive treatment for malaria in Papua New Guinean infants exposed to Plasmodium falciparum and P. vivax: a randomized controlled trial
March 27, 2012
This large, randomised placebo-controlled trial was the first to demonstrate the efficacy of IPTi for the prevention of malaria in children outside Africa and equally the first to prove its efficacy against P. vivax malaria.
Modelling the dynamics of Plasmodium falciparum histidine-rich protein 2 in human malaria to better understand malaria rapid diagnostic test performance
March 19, 2012
Background Effective diagnosis of malaria is a major component of case management. Rapid diagnostic tests (RDTs) based on Plasmodium falciparumhistidine-rich protein…
September 9, 2011
Background The epidemiology of congenital malaria was investigated in a hospital-based malaria surveillance study in Papua, Indonesia. Methods From April…